Dr. Naresh Konduru is an accomplished pharmaceutical scientist and analytical research leader with over 18 years of experience in the pharmaceutical industry. He possesses extensive expertise in Analytical Research & Development (AR&D), Quality & Compliance, regulatory CMC documentation, analytical method development, validation, impurity profiling, and Analytical Quality by Design (AQbD).

He currently serves as General Manager – Analytical (Quality & Compliance) at MASUU Global Solutions Pvt. Ltd., where he leads analytical quality systems, regulatory compliance, GMP audit readiness, and global CMC support. Prior to this role, he worked as a pharmaceutical analytical consultant and held senior leadership positions including Senior Director & Head of Analytical R&D in leading pharmaceutical organizations across China and India, such as Zhuhai Resproly Pharmaceutical Technology, Yunnan Longjin Careyou Pharmaceutical, Zhejiang Xianju Pharmaceutical, NATCO Pharma, AET Laboratories, Granules India, and MSN Laboratories.

His professional expertise spans analytical development for oral solid dosage forms, injectables, inhalation products, peptides, semi-solid formulations, oncology products, and steroid-based pharmaceuticals, supporting regulatory submissions to the US FDA, EMA, CDE (China), Health Canada, and Australian regulatory authorities.

Research Contributions

Dr. Konduru has made significant contributions to pharmaceutical analytical sciences through innovative research in:

• Analytical Quality by Design (AQbD)
• Stability-indicating analytical methods
• RP-HPLC, UPLC, LC-MS/MS, GC-MS, and ICP-MS applications
• Impurity profiling and degradation pathway characterization
• Pharmaceutical method development and validation
• Nitrosamine impurity risk assessment
• Green analytical chemistry
• Regulatory analytical science

His analytical methods have directly supported:

• Three anti-cancer drug products approved in the United States, Canada, and Australia.
• Two finished pharmaceutical products approved in the European Union.
• Multiple inhalation products submitted for Chinese and European regulatory approvals.

Publications, Patents & Scholarly Impact

Dr. Konduru has established a strong international research profile through:

• 27 peer-reviewed publications in SCI, SCIE, ESCI, Web of Science, and Scopus-indexed journals.
• 3 additional manuscripts currently under review.
• 20 published Indian patents with 3 more patent applications under examination.
• Over 410 Google Scholar citations, reflecting the growing impact of his research.
• Numerous publications in prestigious journals including ACS Omega, Biomedical Chromatography, Separation Science Plus, Journal of AOAC International, Analytical Chemistry Letters, Current Science, and others.

His work has advanced pharmaceutical analytical methodologies, regulatory science, chromatography, impurity characterization, and quality-by-design strategies.

Editorial & Scientific Leadership

Beyond research, Dr. Konduru actively contributes to the global scientific community through editorial and peer-review activities.

His professional contributions include:

• Editorial Board Member, The Open Medicinal Chemistry Journal (Bentham Science).
• Reviewer for international Q1–Q3 scientific journals.
• Completion of 170+ peer reviews for international journals.
• Technical mentor and trainer in analytical quality systems, GMP, and regulatory compliance.

Professional Expertise

His major areas of specialization include:

• Analytical Research & Development
• Regulatory CMC Documentation
• AQbD Method Development
• Stability Studies
• Pharmaceutical Quality Systems
• LC-MS/MS & GC-MS Analysis
• Dissolution Method Development
• Impurity Identification & Characterization
• Analytical Method Validation
• Regulatory Compliance (US FDA, EMA, CDE)
• GMP Audit Support
• Pharmaceutical Product Development

Achievements & Recognition

Dr. Konduru's career reflects sustained excellence in pharmaceutical innovation and regulatory science.

Key achievements include:

• Over 18 years of industrial research leadership.
• Development of analytical methods supporting globally approved pharmaceutical products.
• Leadership of multinational analytical research teams across India and China.
• 20 published Indian patents demonstrating innovation in pharmaceutical sciences.
• More than 27 international scientific publications.
• Extensive experience in regulatory submissions across multiple international markets.
• Recognized expertise in AQbD, impurity profiling, and pharmaceutical analytical strategy.

Eligibility for the Excellent Researcher Award

Dr. Naresh Konduru is highly eligible for the Excellent Researcher Award in Scientific Laurels based on his outstanding contributions to pharmaceutical analytical sciences and global drug development.

His eligibility is supported by:

• More than 18 years of distinguished research and industrial leadership.
• Significant contributions to internationally approved pharmaceutical products.
• 27+ high-quality international research publications in reputed indexed journals.
• 20 published Indian patents showcasing innovation in pharmaceutical research.
• Strong scholarly impact with 410+ citations.
• Leadership in multinational pharmaceutical research organizations.
• Extensive expertise in regulatory science, analytical quality by design, and advanced chromatographic techniques.
• Active service to the scientific community through editorial responsibilities and 170+ international peer reviews.

Dr. Naresh Konduru has established himself as a distinguished pharmaceutical analytical scientist whose work bridges industrial innovation, regulatory excellence, and scientific research. His extensive publication record, patented innovations, global regulatory experience, and leadership in analytical research make him a highly deserving candidate for the Excellent Researcher Award under the Scientific Laurels program.